Report Details:
15 Companies Covered
110 Pages
Pune, India, June, 2023 /MRFR Press Release/- Market Research Future has a half cooked research report on the global molecular modelling market.
Global Molecular Modelling Market Highlights
The global molecular modelling market is expected to grow at a CAGR of 9.10% during the forecast period 2023-2032 to worth MRFR USD 6.65 Billion by 2032.
Molecular modelling is a widely used tool in the field of pharmaceutical industries and chemistry for the drug development. It investigate, interpret, explain, and discover new phenomenon of molecules. Molecular modeling is easy to perform with currently available software, but it is difficult get right model and proper interpretation. The major driving factors for the market are increasing investments in R&D, increasing prevalence of chronic diseases, and increasing demand for the better treatment. According to the World Health Organization (WHO), chronic diseases are the leading cause of mortality across the world, representing around 60% of all deaths.
Changing lifestyle and increasing geriatric population have increased the probability of causing the different diseases. In addition to this, technological advancements, increasing need for the cost-effective treatment and growth in the biology and biosimilars markets have fuelled the market growth. However, high cost of the research and limited availability of skilled professional may affect the growth of the market over the assessment period, negetively.
Regional Analysis
The Americas dominates the global molecular modelling market owing to the presence of huge patient population, high healthcare spending, and increasing government support for research & development. Europe is the second largest global molecular modelling market followed by Asia Pacific. The growth of the European market is majorly attributed to the increasing government support, and high healthcare spending.
Asia Pacific is the fastest growing molecular modelling market. Japan holds the major share of the regional market. Whereas, China and India are the fastest growing market due to rapidly growing economy, increasing healthcare expenditure, and government initiatives for research & development.
The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
Segmentation
The global molecular modelling market has been segmented on the basis of approach, application, product, and end user.
On the basis of approach, the market is segmented into molecular mechanics approach, and quantum chemistry approach.
On the basis of product, the market is segmented into instruments, reagents, kits, and others.
On the basis of application, the market is segmented into drug development, drug discovery, and other application. Drug discovery is further segmented into direct drug design, indirect drug design, and molecular mimicry. The direct drug design is sub-segmented into lead identification, target identification, and others. Indirect drug design is sub-segmented into pharmacophore, quantitative structure-activity relationships (QSAR), and others.
On the basis of end user, the market is segmented into pharmaceutical & biotechnological companies, research organizations, and others.
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Molecular Modelling Market Research Report
Key Players
Some of key players in the market are Fisher Scientific Company LLC. (US), Indigo Instruments (US), Simulation Plus (US), Certara, L.P. (US), Dassault Systèmes (France), Advanced Chemistry Development (Canada), Schrödinger, LLC (US), Genedata AG (Switzerland), Chemical Computing Group ULC (Canada), Physiomics PLC (UK), and Entelos, Inc. (US).